Aviso Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.02M Sell
16,452
-649
-4% -$151K 1.81% 15
2025
Q4
$3.54M Sell
17,101
-1,068
-6% -$211K 1.49% 18
2025
Q3
$3.37M Buy
18,169
+438
+2% +$75K 1.47% 18
2025
Q2
$2.71M Sell
17,731
-206
-1% -$31.7K 1.26% 18
2025
Q1
$2.97M Buy
17,937
+2,218
+14% +$347K 1.58% 14
2024
Q4
$2.27M Buy
15,719
+4,081
+35% +$632K 1.16% 16
2024
Q3
$1.89M Sell
11,638
-121
-1% -$19.3K 1.02% 25
2024
Q2
$1.72M Sell
11,759
-46
-0.4% -$6.84K 1.02% 21
2024
Q1
$1.87M Sell
11,805
-26
-0.2% -$4.14K 1.18% 19
2023
Q4
$1.85M Buy
+11,831
New +$1.81M 1.34% 15

Other funds holding JNJ

Aviso Wealth Management's JNJ Position: Q1 2026 in Review

Aviso Wealth Management reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q1 2026, selling an estimated $151K and leaving 16,452 shares worth $4.02M. The position accounts for 1.81% of the portfolio, ranked #15.

Aviso Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aviso Wealth Management held 16,452 shares of Johnson & Johnson worth $4.02M as of Q1 2026.
  • Aviso Wealth Management sold 649 Johnson & Johnson shares in Q1 2026, an estimated $151K.
  • Johnson & Johnson made up 1.81% of Aviso Wealth Management's portfolio in Q1 2026, its #15 holding.
  • Aviso Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aviso Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.